Zepbound 7.5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F72MA
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $32,685
Award facts
- Contract value 100% obligated
- $32,685.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $32,685.20 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 mL pens on November 24, 2025, with an ultimate completion date of November 25, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a single delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is the vendor's corporate office in Conshohocken, Pennsylvania. Zepbound is a tirzepatide-based pharmaceutical product used for weight management and diabetes treatment, falling within the company's established portfolio of specialty medications and injectable pharmaceutical products supplied to federal healthcare systems.
This delivery order is issued under AmerisourceBergen's substantial prime Indefinite Delivery Vehicle designated SPE2DX, valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support contract for the DLA Troop Support Medical Supply Chain. The company, a major pharmaceutical distributor headquartered in Pennsylvania, has demonstrated extensive capability in fulfilling federal medical procurement requirements across multiple therapeutic domains. The underlying IDC enables AmerisourceBergen to supply a broad range of pharmaceutical products, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs, the Defense Health Agency, the U.S. Coast Guard, and other government healthcare systems worldwide.
Quick answers
Who was awarded contract SPE2DR26F72MA?
SPE2DR26F72MA was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 24, 2025.
How much is contract SPE2DR26F72MA worth?
The government has obligated $32,685 on SPE2DR26F72MA.
Is contract SPE2DR26F72MA an order under another contract?
Yes. SPE2DR26F72MA is a delivery order under SPE2DR25D1202, an indefinite delivery contract.
Was contract SPE2DR26F72MA competed?
The extent of competition for SPE2DR26F72MA was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award